EMEA-000713-PIP02-10-M05
Key facts
| Invented name |
Pixuvri
|
| Active substance |
pixantrone (dimaleate)
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0227/2018
|
| PIP number |
EMEA-000713-PIP02-10-M05
|
| Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of non-Hodgkin lymphoma
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
CTI Life Sciences Limited
Tel. +1 2062724260 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|